skip to main content
back

Press Releases

11 Nov 2003

Roger Jeffs, Ph.D. Adopts 10b5-1 Trading Plan
Download pdf

11 Nov 2003

United Therapeutics Granted Additional Arginine Supplementation Patent Over Prior Art
Download pdf

10 Nov 2003

Remodulin Long-Term Data Presented At American Heart Association Conference
Download pdf

06 Nov 2003

United Therapeutics Reports Third Quarter 2003 Financial Results
Download pdf

30 Oct 2003

United Therapeutics To Announce Third Quarter Financial Results Before Market Open On November 6, 2003
Download pdf

07 Oct 2003

Stuart Rich, M.D. Joins United Therapeutics as Chief Medical Officer
Download pdf

02 Oct 2003

Remodulin Long-Term Data Presented at European Respiratory Society Conference
Download pdf

22 Sep 2003

European Approval of Remodulin Delayed
Download pdf

08 Sep 2003

United Therapeutics Engages Ernst & Young As Independent Public Accountants
Download pdf

21 Aug 2003

FDA Extends Timeline For Completion of Remodulin Pase IV Study
Download pdf

05 Aug 2003

United Therapeutics Reports Second Quarter 2003 Financial Results
Download pdf

29 Jul 2003

United Therapeutics to Announce Second Quarter Financial Results Before Market Open On August 5, 2003
Download pdf

(Showing 457 – 468 of 527)